FDA “Rapid-Action” Team, Pre-Emption Included In GOP Bioterror Bill
Executive Summary
The Senate leadership's biodefense bill for 2005 would direct FDA to create a special compliance unit to help prevent shortages of vaccines
You may also be interested in...
Hatch/Lieberman “BioShield II” Sets 180-Day Window For “Wild Card” Patents
Manufacturers who enter into biodefense contracts must notify the government within 180 days which patent would be covered by a potential "wild card" extension under the final version of "BioShield II" legislation from Sens. Orrin Hatch (R-Utah), Joe Lieberman (D-Conn.) and Sam Brownback (R-Kan.)
Hatch/Lieberman “BioShield II” Sets 180-Day Window For “Wild Card” Patents
Manufacturers who enter into biodefense contracts must notify the government within 180 days which patent would be covered by a potential "wild card" extension under the final version of "BioShield II" legislation from Sens. Orrin Hatch (R-Utah), Joe Lieberman (D-Conn.) and Sam Brownback (R-Kan.)
Unused Flu Vaccine Would Be Purchased By HHS Under Draft “BioShield II”
The Centers for Disease Control & Prevention would purchase a percentage of unused influenza vaccine doses at the end of each flu season under a draft version of the "BioShield II" bill